Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Vaccines01:30

Cancer Vaccines

437
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
437
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

74
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
74
Tumor Immunotherapy01:27

Tumor Immunotherapy

577
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
577
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Therapeutic Strategies for Hepatocellular Carcinoma: Current Advances and Future Perspectives.

Vaccines·2026
Same author

Tumor-targeted multifunctional extracellular vesicles as drug carriers for lung cancer therapy.

Extracellular vesicles and circulating nucleic acids·2026
Same author

BRG1 (SMARCA4) Status Dictates the Response to EGFR Inhibitors in Wild-Type EGFR Non-Small Cell Lung Cancer.

Cancers·2026
Same author

Therapeutic Colorectal Cancer Vaccines: Emerging Modalities and Translational Opportunities.

Vaccines·2025
Same author

Combating Emerging Respiratory Viruses: Lessons and Future Antiviral Strategies.

Vaccines·2024
Same author

<i>In vivo</i> safety evaluation and tracing of arginylglycylaspartic acid-engineered phage nanofiber in murine model.

Journal of materials chemistry. B·2024

Related Experiment Video

Updated: Jul 29, 2025

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

9.5K

Engineered Phage-Based Cancer Vaccines: Current Advances and Future Directions.

Murali Ragothaman1, So Young Yoo1

  • 1BIO-IT Foundry Technology Institute, Pusan National University, Busan 46241, Republic of Korea.

Vaccines
|May 27, 2023
PubMed
Summary

Bacteriophages (phages) are engineered for targeted cancer therapy, acting as vaccines and drug carriers. Their genetic potential offers new strategies for cancer treatment and immunotherapy.

Keywords:
bacteriophagescancer immunotherapycombination therapygene therapyimmunological responsenanocarrierphage display

More Related Videos

Author Spotlight: Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction
10:18

Author Spotlight: Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction

Published on: July 7, 2023

1.3K
A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
09:56

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

677

Related Experiment Videos

Last Updated: Jul 29, 2025

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

9.5K
Author Spotlight: Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction
10:18

Author Spotlight: Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction

Published on: July 7, 2023

1.3K
A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
09:56

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

677

Area of Science:

  • Bioengineering
  • Immunology
  • Oncology

Background:

  • Bacteriophages (phages) are increasingly utilized in bioengineering for applications like tissue engineering and immunotherapy.
  • Their genetic properties enable the development of DNA vaccines and antigen display systems for enhanced immune response.
  • Phages offer novel strategies for targeting cancer cells and delivering therapeutics.

Purpose of the Study:

  • To review the role of bacteriophage engineering in targeted cancer therapy.
  • To explore the mechanisms of engineered phage interaction with biological and immunological systems for cancer immunotherapy.
  • To discuss phage display technology and phage engineering for developing novel cancer treatments.

Main Methods:

  • Literature review focusing on bacteriophage applications in cancer therapy.
  • Analysis of phage display technology for identifying cancer-specific ligands.
  • Examination of phage engineering strategies for therapeutic development.

Main Results:

  • Engineered bacteriophages show potential as anticancer agents, vaccine platforms, and carriers for imaging and therapeutics.
  • Phage display technology effectively identifies high-affinity ligands for cancer cells and tumor-associated molecules.
  • Phage engineering advances offer new avenues for effective cancer treatments and vaccines.

Conclusions:

  • Bacteriophage engineering holds significant promise for targeted cancer therapy and immunotherapy.
  • Understanding phage-host interactions is crucial for optimizing phage-based cancer treatments.
  • This review highlights the potential of engineered phage-based cancer vaccines and their clinical relevance.